Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
FBRX on Nasdaq
Shares outstanding
12,586,921
Price per share
$26.65
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
10,343,866
Total reported value
$155,080,846
% of total 13F portfolios
0%
Share change
+391,054
Value change
+$6,727,909
Number of holders
42
Price from insider filings
$26.65
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FEDERATED HERMES, INC. 13% +10% $18,692,393 +$1,791,458 1,635,380 +11% Federated Hermes, Inc. 30 Sep 2025
ALGER ASSOCIATES INC 13% -1.5% $24,514,005 +$234,270 1,634,267 +0.96% Alger Associates, Inc. 30 Sep 2025
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 10% 0% $13,378,307 +$6,618,184 1,268,086 +98% TYBOURNE CAPITAL MANAGEMENT (HK) LTD 30 Jun 2025
Affinity Asset Advisors, LLC 6.9% $16,437,344 862,400 Affinity Asset Advisors, LLC 17 Dec 2025
Point72 Asset Management, L.P. 6.3% $21,132,810 792,976 Point72 Asset Management, L.P. 12 Jan 2026
JANUS HENDERSON GROUP PLC 9.9% 0% $6,936,720 657,509 0% JANUS HENDERSON GROUP PLC 30 Jun 2025
Ikarian Capital, LLC 5% -45% $6,516,387 +$89,063 617,667 +1.4% Ikarian Capital, LLC 30 Jun 2025
ORBIMED ADVISORS LLC 8% $3,763,800 510,000 ORBIMED ADVISORS LLC 31 Dec 2024
Oliveira Steven Michael 2.4% -62% $6,797,265 -$2,993,786 300,100 -31% Oliveira Steven Michael 08 Jan 2026
PERCEPTIVE ADVISORS LLC 2.5% $1,209,840 163,935 Perceptive Advisors LLC 31 Dec 2024
BIOTECHNOLOGY VALUE FUND L P 0.5% -95% $980,250 -$8,674,080 65,350 -90% BVF PARTNERS L P/IL 30 Sep 2025
BOOTHBAY FUND MANAGEMENT, LLC 0.8% -87% $567,495 -$369,187 53,791 -39% Boothbay Fund Management, LLC 30 Jun 2025

As of 30 Sep 2025, 42 institutional investors reported holding 10,343,866 shares of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX). This represents 82% of the company’s total 12,586,921 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) together control 82% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FRED ALGER MANAGEMENT, LLC 13% 1,636,030 +1.1% 0.1% $24,540,450
FEDERATED HERMES, INC. 13% 1,635,380 +53% 0.04% $24,530,700
JANUS HENDERSON GROUP PLC 11% 1,403,842 +0.64% 0.01% $20,980,419
ORBIMED ADVISORS LLC 9.5% 1,196,955 0% 0.43% $17,954,325
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 6.2% 786,647 0% 38% $11,799,705
VANGUARD GROUP INC 4.5% 566,741 +16% 0% $8,501,115
Cable Car Capital, LP 4% 500,000 0% 3.2% $7,500,000
SPHERA FUNDS MANAGEMENT LTD. 3.8% 474,309 -4.2% 1.7% $7,114,635
ADAGE CAPITAL PARTNERS GP, L.L.C. 2.6% 333,333 0% 0.01% $4,999,995
Woodline Partners LP 2.6% 331,987 0% 0.02% $4,979,805
Ikarian Capital, LLC 2.4% 300,000 -37% 1% $4,500,000
AWM Investment Company, Inc. 2.1% 261,821 0.37% $3,927,315
FMR LLC 1.9% 244,400 0% $3,666,000
MILLENNIUM MANAGEMENT LLC 0.95% 119,812 +66% 0% $1,797,180
GEODE CAPITAL MANAGEMENT, LLC 0.86% 108,318 +69% 0% $1,625,099
Mink Brook Asset Management LLC 0.65% 81,312 +109% 0.82% $1,219,680
AMERIPRISE FINANCIAL INC 0.56% 69,892 0% $1,048,380
BVF INC/IL 0.52% 65,350 -89% 0.04% $980,250
BlackRock, Inc. 0.4% 50,662 +50% 0% $759,930
STATE STREET CORP 0.3% 38,097 0% $571,455
ENVESTNET ASSET MANAGEMENT INC 0.19% 23,347 +24% 0% $350,205
NORTHERN TRUST CORP 0.18% 23,285 0% $349,275
MARSHALL WACE, LLP 0.15% 19,165 0% $287,475
RENAISSANCE TECHNOLOGIES LLC 0.13% 16,200 0% $243,000
CITADEL ADVISORS LLC 0.12% 15,633 0% $234,495

Institutional Holders of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 10,343,866 $155,080,846 +$6,727,909 $15.00 42
2025 Q2 9,809,779 $127,063,335 +$62,289,077 $12.93 33
2025 Q1 5,034,489 $39,316,245 +$4,704,465 $7.76 29
2024 Q4 4,275,821 $97,104,372 +$81,936,549 $22.71 26
2024 Q3 736,630 $4,120,236 +$4,082,162 $5.59 23